Skip to main content
. 2016 Jan 19;5:e11394. doi: 10.7554/eLife.11394

Figure 7. HEG1-binding deficient Rasip1 fails to rescue MLC phosphorylation and EC permeability.

(A and B) Myosin light chain phosphorylation (pMLC) was analyzed by Spinning Disk Confocal Microscopy (SDCM) in Human Umbilical Vein Endothelial Cells (HUVEC), infected as indicated (A). Integrated Density was measured to quantify levels of pMLC expression (B). Lentiviral depletion of Rasip1 (shRasip1) increased levels of pMLC in HUVEC by 40% compared to control cells (shCtrl) which can be rescued by expression of FLAG-tagged shRasip1-resistant wild-type Rasip1. In contrast, HEG1-binding deficient Rasip1(∆334-539) failed to rescue pMLC expression. Expression of rescue constructs is shown by FLAG staining. Mean values ± SEM are shown. One-way analysis of variance (ANOVA) with Bonferroni’s test was used to compare each condition versus Rasip1-depleted cells (shRasip1). Data are from 3 independent experiments. Scale bars, 10 µm. (C) pMLC expression was analyzed by SDCM in control HUVEC (shCtrl) or HUVEC expressing FLAG-tagged Rasip1(∆334-539) (shCtrl+∆334-539). Expression of Rasip1(∆334-539) alone induces expression of pMLC similar to Rasip1 knock-down (Panel A). Scale bars, 10 µm. (D and E) Permeability of HUVEC, seeded on fibronectin-coated Transwell filters (pore size 0.4 μm, membrane diam. 12 mm) and infected as indicated, was measured using 70kD-FITC-Dextran (D). Western blot analysis confirmed Rasip1 knock-down and expression of FLAG-tagged rescue constructs (E). Depletion of Rasip1 (shRasip1) increased permeability by two-fold compared to control cells (shCtrl) which can be rescued by expression shRasip1-resitant wild-type Rasip1. In contrast, HEG1-binding deficient Rasip1(∆334-539) failed to rescue HUVEC permeability. Mean values ± SEM are shown. One-way analysis of variance (ANOVA) with Bonferroni’s test was used to compare each condition versus control cells (shCtrl). Data are from 3 independent experiments. See also Figure 7—figure supplement 1.

DOI: http://dx.doi.org/10.7554/eLife.11394.014

Figure 7.

Figure 7—figure supplement 1. Generating FLAG-Rasip1 shRNA-resistant cDNA.

Figure 7—figure supplement 1.

(A) Silent mutations have been introduced in FLAG-tagged Rasip1 to render it resistant to shRNA-mediated depletion of Rasip1 protein levels. HEK293T cells were transfected with wild-type or shRNA resistant Rasip1 and co-transfected with either control shRNA (shCtrl) or Rasip1-specific shRNA (shRasip1). Western blot analysis shows that Rasip1 shRNA-resistant protein levels are not reduced when co-transfected with shRNA targeting Rasip1. (B) shRNA-resistant Rasip1 was cloned into a lentiviral expression vector (2K7). Human Umbilical Vein Endothelial Cells (HUVEC) were infected with lentiviral particles containing control shRNA (shCtrl) or Rasip1-specfic shRNA (shRasip1). Endogenous Rasip1 protein levels are reduced upon expression of shRasip1. In contrast, lentivirally expressed Rasip1 (shRNA resistant) protein levels are not affected by expression of shRasip1.